Minimally Invasive Spine Technologies Market Assessment, By Technique [Endoscopy, Navigation, Robotics], By Condition [Herniated Disc, Spinal Stenosis, Degenerative Disc Disease, Spinal Deformity, Spinal Fracture, Spinal Infection, Spinal Tumor], By End-u

Minimally Invasive Spine Technologies Market Assessment, By Technique [Endoscopy, Navigation, Robotics], By Condition [Herniated Disc, Spinal Stenosis, Degenerative Disc Disease, Spinal Deformity, Spinal Fracture, Spinal Infection, Spinal Tumor], By End-user [Hospitals, Ambulatory Surgical Centers, Orthopedics Clinics], By Region, Opportunities and Forecast, 2017-2031F

Global minimally invasive spine technologies market is projected to witness a CAGR of 9.36% during the forecast period 2024-2031, growing from USD 1.21 billion in 2023 to USD 2.48 billion in 2031F. The minimally invasive spine technologies market is anticipated to thrive under the influence of factors such as the growing demand for minimally invasive surgeries, the rising prevalence of spine disorders, enhanced patient safety and compliance through such surgeries, and technological advancements in surgical tools.

Minimally invasive spine technologies refer to surgical techniques and technologies that aim to minimize surgical morbidity and achieve surgical outcomes as traditional open surgery while reducing iatrogenic tissue trauma and postoperative pain and disability in spine surgeries. Minimally invasive spine technologies have expanded their utility to simple spinal stenosis and complex spinal pathologies such as metastasis, trauma, or adult spinal deformity. The techniques and technology in minimally invasive spine technologies include spinal endoscopy, intraoperative fluoroscopy/CT, and minimally invasive spinal instrumentation technologies.

In upcoming years, the demand for minimally invasive spine surgeries is expected to grow owing to its multifactorial advantages, such as reduced hospital stay, lesser trauma, and faster recovery, which ultimately expands the growth of the minimally invasive spine technologies market.

However, the major challenge to the market is the high cost of instruments used and the complexities of procedures. Strict regulatory requirements and approval processes for such surgeries are tricky for manufacturers. Challenges associated with adopting robotics and technology in surgery hinder market growth. Lack of technical expertise and training modules associated with minimally invasive surgeries is another major challenge for the market.

In January 2024, Providence Medical Technology announced FDA approval of CAVUX FFS-LX Lumbar Facet Fixation System for 1st and 2nd level lumbar spinal fusion. CAVUX FFS-LX is a bilateral implant system for treating lumbar degenerative disc disease. It is a cage and screw system that provides stabilization for first or second-level lumbar interbody fusion. It can be used with or without pedicle screws and rods and is implanted using the CORUS Spinal System-LX.

Growing Demand for Minimally Invasive Spine Surgeries

The demand for minimally invasive spine surgeries is increasing due to various factors such as advanced techniques, improved pain management, and economic considerations. The current state of minimally invasive spine surgery has witnessed significant technological advancements, making these approaches more efficient and effective for managing different spinal disorders. The emergence of outpatient minimally invasive spine surgery is driven by the need to balance the desire to treat patients with a clear understanding of the economic implications of healthcare. The cost of surgery must be weighed against the societal cost of back pain, which is quite high. Minimally invasive spine surgeries are associated with reduced intraoperative blood loss, postoperative pain, and greater and earlier restoration of function. Key players actively make product launches to cater to the growing demand.

For instance, in December 2023, Ulrich Medica USA announced that it got FDA clearance to expand indications for its Momemtum and Momentum minimally invasive posterior spine systems. The systems can be used with G21 V-STEADY radiopaque bone cement to stabilize, fix, and correct the thoracolumbar and sacroiliac spine.

Growing Prevalence of Spine Disorders

The minimally invasive spine technologies market is expected to expand due to the increasing prevalence of spinal disorders. The elderly population is more susceptible to spinal disorders due to wear and tear of the spine that comes with aging. It is expected to lead to a significant increase in spinal disorder cases. Factors such as obesity, long hours of sitting among working professionals, nutritional deficiencies, lack of physical exercise, and a high number of accidents leading to spinal injuries are expected to contribute to a high prevalence of spinal disorders. Inherited disorders, inflammations, and infections that damage the spine contribute to the growth in the prevalence of spinal disorders.

According to estimates by World Spine Care, around 1 billion people worldwide suffered from spine pain. Each year, approximately 72% of the global population is expected to experience back pain, while around 59% of people are identified with back pain at any given time. Lower back pain is the primary cause of disability, and neck pain is the fourth leading cause of disability, globally, as estimated by World Spine Care.

Technological Advancements in Minimally Invasive Spine Surgery

Minimally invasive spine surgery has seen significant technological advancements in recent years. Some of the most important technological developments include employing an endoscope in spine surgery, navigation-guided spinal fusion, and O-arm navigation in spine surgery. With technical and technological advancements, MISS has expanded its utility to simple spinal stenosis and complex spinal pathologies such as metastasis, trauma, or adult spinal deformity. Robotic systems are expected to become a bigger part of spine surgery. Research and developments by key market players and stakeholders to produce innovative solutions are driving the demand in the market.

In May 2023, Globus Medical, Inc. received approval from the US Food and Drug Administration for its first humanitarian device, the REFLECT Scoliosis Correction System. The system is designed to correct progressive scoliosis in young patients while preserving motion, maintaining stability, and allowing for future modulated growth.

Dominance of Endoscopy Segment

Endoscopy technology used for minimally invasive spine surgeries is anticipated to be the leading segment. Endoscopic spinal surgeries offer advantages such as less soft tissue dissection, reduced blood loss, minimal damage to normal structures, decreased epidural scarring, shorter hospital stay, and earlier functional recovery, thus preferred over other spinal surgeries. Additionally, endoscopic spine surgery can effectively treat conditions such as herniated discs, bulging discs, foraminal stenosis, and degenerative lumbar disease. Several product launches have happened to cater to the endoscopic spinal surgery market.

In October 2023, Joimax launched a new surgical system called the iLESSYS Biportal Interlaminar Endoscopic Surgical System. The system was introduced at two major events, EUROSPINE 2023 Annual Meeting in Frankfurt and SMISS Annual Forum (Society for Minimally Invasive Spine Surgery) in Las Vegas. The iLESSYS Biportal is designed to treat spinal disorders and features a set of instruments tailor-made for biportal spinal endoscopy. One of the system's key features is that it separates the instrument's working port from the endoscope, allowing for greater flexibility and range of motion during surgery.

Ambulatory Surgical Centers to be the Fastest Growing End-user Segment

New techniques, better anesthesia, and improved pain control make same-day back surgeries outstanding growth opportunities for ambulatory settings. Owing to the advantages of ambulatory surgical centers, such as reduced hospital stays, higher success rates, and lower costs, there is an increased number of spinal surgeries being performed at ambulatory surgical centers, showing a drastic shift from preference to hospital settings to ambulatory setups. Additionally, surgeons prefer ambulatory surgical centers to reduce hospital resource utilization. Overall, the clinical advantages of outpatient spine surgery are beneficial, but it has economic advantages that are most convincing in the case of ambulatory surgical centers. For instance, the Ambulatory Surgery Center Association reports an 80% increase in surgeries performed at ASCs.

North America to Dominate the Market

The number of minimally invasive spine surgeries performed in the United States is higher than in other countries due to several factors, including the widespread employment of minimally invasive and endoscopic spinal surgery techniques by spine surgeons in the United States. While Asia is a hotspot for these techniques, the United States is renowned for its excellence in minimally invasive spine surgery, offering patients quicker recovery times, reduced pain, and minimal scarring.

Regional variations in acceptance and utilization of minimally invasive spinal surgery techniques among spine surgeons play a role, with the United States showing a high level of acceptance and utilization of these techniques. The United States being a highly contributing country in North America, helps in establishing dominance of the region in the minimally invasive spine technologies market.

Future Market Scenario (2024 – 2031F)

Accelerated development of innovative robotic-assisted spine surgeries is anticipated to exponentially expand the minimally invasive spine technologies market in the future. Regulatory emphasis on developing and approving such products drives further market expansion. For instance, in August 2023, Wenzel Spine received clearance from the US Food and Drug Administration (FDA) for its primaLOK SP system. According to the company, it marks a significant advancement in spinal fusion technology, providing surgeons and patients with a highly effective and reliable solution for spinal stabilization. The primaLOK SP system incorporates innovative engineering and patient-focused design, offering a comprehensive solution for spinal fusion procedures. The latest FDA clearance allows for the primaLOK SP system to be used at multiple levels, including the treatment of patients with lumbar spinal stenosis.

Key Players Landscape and Outlook

The key players in the minimally invasive spine technologies market are engaged in product development, strategic alliances, and business growth strategies such as partnerships, agreements, and collaborations to drive market value. Regulatory approvals for new products and services and expansion of permitted indications for existing products drive the growth of players and the market.

In May 2023, Novarad's VisAR, a surgical navigation system that employs augmented reality, gained clearance from Indonesia's FDA for intraoperative use in stereotactic spinal surgery. VisAR is effective in both open and minimally invasive surgery (MISS). Advanced technology enables surgeons to convert a patient's imaging data into a 3D hologram that can be precisely projected onto the patient's body. It helps surgeons focus purely on the surgical goal without diverting their attention to a separate monitor, allowing for accurate surgical guidance.